CURE’s breast cancer page is an extensive resource of cancer information featuring the latest breast cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on breast cancer.
September 27th 2024
As a caregiver to my daughter who had breast cancer, pink takes on a new meaning for us — one I’m not quite a fan of.
September 25th 2024
September 23rd 2024
September 18th 2024
FDA Grants Priority Review to Tecentriq Combination for Triple Negative Breast Cancer
November 13th 2018The Food and Drug Administration granted a priority review to Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for the frontline treatment of unresectable locally advanced or metastatic triple-negative breast cancer (TNBC) in patients whose disease expresses the PD-L1 protein, as determined by PD-L1 biomarker testing, according to Roche, the drug’s manufacturer.